维普期刊资源整合服务平台（V6.5）

77篇 您的检索式：作者名="Sandier AB"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Select clinical trials of erlotinib ( OSI- 774) in non-small-cell lung cancer with emphasis on phase III outcomes显示文摘	Fuster LM Sandier AB	2004	Clin Lung Cancer2004，1，：	1
2	Risk of symptomatic central nervous system (CNS) progression and secondary hemorrhage in patients with non-squamous non-small cell lung cancer (NSCLC) receiving bevacizumab ( BV ) -based first-line therapy 显示文摘	Archer V Reck M Sandier AB	2008	J Clin Oncol2008，26，：	1
3	Phase Ⅲ trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer 显示文摘	Sandier AB Nemunaitis J Denham C	2000	J Clin Oncol2000，18，1：	1
4	First-line treatment for advanced non-small-cell lung cancer 显示文摘	Laskin JJ Sandier AB	2005	Ontology (Williston Park)2005，19，13：	1
5	Select clinical trials of erlotinib(OSI-774)in non-smal-l cell lung cancer with emphasis of phaseⅢoutcomes显示文摘	Fuster LM Sandier AB	2004	Clin Lung Cancer2004，6，1：	1
6	First-line treatment for advanced non-small cell lung cancer 显示文摘	Laskin JJ Sandier AB	2005	Oncology2005，19，13：	1
7	Phase Ill trial of ge- meitabine plus cisplatin vesus cisplatin alone in patients with local- ly advanced or metastatic non--small--cell lung cancer显示文摘	Sandier AB Nemumaitis J Denham C	2000	J Clin Onco12000，18，：	1
8	First-line treatment for advanced nonsmall cell lung cancer 显示文摘	Laskin JJ Sandier AB	2005	Oncology ( Williston Park )2005，19，13：	1
9	Select clinical trials of erlotinib(OSI-774) in non-small cell lung cancer with emphasis on phase Ⅲ outcomes显示文摘	Fuster LM Sandier AB	2004	Clin Lung Cancer2004，6，1：	1
10	An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation显示文摘	Mukherjee T Sandier B Copperman AB	1996	Fertil Steril1996，65，3：	1
11	The rationale for adjuvant chemotherapy in stage Ⅰ non - small cell lung cancer显示文摘	Horn L Sandier AB Putnam JB J r	2007	J Thorac Oncol2007，2，5：	1
12	Inhibition of angiogenesis in the treatment of non-small cell lung cancer显示文摘	Keedy VL Sandier AB	2007	Cancer Sei2007，98，12：	1
13	Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase Ⅱ trial in patients with metastatic nonsmall cell lung carcinoma 显示文摘	Sweeney CJ Zhu J Sandier AB	2001	Cancer2001，92，10：	1
14	A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC) 显示文摘	Jain AK Hughes RS Sandier AB	2009	J Thorac Oncol2009，4，6：	1
15	Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study 显示文摘	Hanna NH Sandier AB Loehrer PJ Sr	2002	Ann Oncol2002，13，1：	1
16	Randomized phase Ⅱ/ Ⅲ trial of paclitaxel plus carboplatin with or without bevacizumab in patients with advanced non-squamous non-smaUcell lung cancer: An Eastern Cooperative Oncology Group Trial-- E4599 显示文摘	Sandier AB Gray R Brahmer J	2005	Clin Oncol2005，23，16：	1
17	An elevated day three follicle - stimulating hormone: luteinizing hormone ratio (FSH: LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation 显示文摘	Mukher jee T Sandier B Coppenman AB	1996	Fertil Steril1996，65，3：	1
18	Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: A Phase Ⅱ trial in patients with metastatic nonsmall cell lung carcinoma 显示文摘	Sweeney CJ Zhu J Sandier AB	2001	Cancer2001，92，10：	1
19	Select clinical trials of erlotinib (OSI-774) in non-small-cell lung cancer with emphasis on phase Ⅲ outcomes 显示文摘	Fuster LM Sandier AB	2004	Clin Lung Cancer2004，1，：	1
20	Outcome of patientswith a performance status of 2 in Eastern Cooperative Ontology Group Study E1594: a Phase Ⅱ trial in patientswith metastatic nonsmall cell lung carcinoma显示文摘	Sweeney CJ Zhu J Sandier AB	2001	Cancer2001，92，10：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示